<DOC>
	<DOCNO>NCT00453063</DOCNO>
	<brief_summary>This study design assess effectiveness mometasone furoate nasal spay ( MFNS ) daily ( QD ) compare placebo subject seasonal allergic rhinitis ( SAR ) reduce total nasal symptom score total ocular symptom score .</brief_summary>
	<brief_title>Placebo-Controlled Study Mometasone Furoate Nasal Spray ( MFNS ) 200 mcg Once Daily ( QD ) Treatment Seasonal Allergic Rhinitis ( Study P05067 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>Must 12 year age old , either sex race . Must least 2year documented history SAR exacerbate study season . Must positive skinprick test response appropriate seasonal allergen Screening ( Visit 1 ) . Immunoglobulin E ( IgE ) mediate hypersensitivity appropriate seasonal allergen ( ie , prevail tree and/or grass ) must document positive response skin prick test wheal diameter least 3 mm large diluent control 20 minute . Must clinically symptomatic Screening Visit . Must clinically symptomatic Baseline Visit . Must general good health confirm routine clinical laboratory test electrocardiogram ( ECG ) result . Clinical laboratory test ( complete blood count [ CBC ] , blood chemistry , urinalysis ) must within normal limit clinically acceptable investigator sponsor . Must free clinically significant disease , SAR , would interfere study evaluation . A history anaphylaxis and/or severe local reaction ( ) skin test . A subject asthma require chronic use inhale systemic corticosteroid . Current history frequent , clinically significant sinusitis chronic purulent postnasal drip . A subject rhinitis medicamentosa . A history allergies two class medication allergic tolerate nasal spray . A subject upper respiratory tract sinus infection require antibiotic therapy without least 14day washout prior Screening Visit , viral upper respiratory infection within 7 day Screening Visit . A subject nasal structural abnormality , include large nasal polyp mark septal deviation , significantly interfere nasal air flow . A subject , opinion investigator , dependent nasal , oral , ocular decongestant , nasal topical antihistamine , nasal steroid .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>